NCT06450106View on ClinicalTrials.gov

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Prostate Cancer
Interventions
DRUG

STM-416p

STM-416p monotherapy

Trial Locations (4)

3051

RECRUITING

Australian Prostate Center, Melbourne N.

RECRUITING

Epworth HealthCare, Melbourne N.

32608

RECRUITING

University of Florida, Gainesville

85715

RECRUITING

Arizona Urology Specialists, Tucson

Sponsors

Lead Sponsor

SURGE Therapeutics
All Listed Sponsors
lead

SURGE Therapeutics

INDUSTRY

NCT06450106 - Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy | Biotech Hunter | Biotech Hunter